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Summary People at risk from coronary heart disease and large bowel cancer are drawn from the same
urbanised, industrialised Western populations. Whilst changes in blood lipids are well recognised in heart
disease, little is known of their role in large bowel cancer. This study investigates serial alterations in blood
lipids in the 1,2-dimethylhydrazine (DMH) rat model of colon cancer. Eighty Wistar rats received a 5 weekly
regimen of DMH. At week 10, and at 5 weekly intervals until week 40, random groups of 10 rats were killed
and blood taken for total and free cholesterol, phospholipids, triglycerides and liver enzymes. All colonic
neoplasms were histologically classified either as adenomas or carcinomas with groups being allocated into
tumour-free (n = 16) or tumour-bearing (n = 54), the latter group being further sub-divided into animals with
adenoma alone (n=8) and those with carcinoma (n =46). Results were considered both sequentially and
according to tumour status. Sequential results showed that with increase in colonic neoplasms with time there
were accompanying increases in free and % free cholesterol and in phospholipids (P<0.001). There were no
changes in total cholesterol, triglycerides or liver enzymes. Results according to tumour status showed that
whilst there was no difference in total cholesterol or triglycerides between tumour-free and tumour-bearing
rats, there was a significant increase in free (P<0.01) and % free cholesterol (P<0.001) and a decrease in
phospholipids in the tumour-bearing animals (P<0.001). There was no difference in any serum lipid between
tumour-free and adenoma-bearing rats. In animals with carcinoma, while there was no difference in total
cholesterol or triglycerides, there was an increase in free (P<0.005) and % free cholesterol (P<0.001) and a
decrease in phospholipids (P<0.001) compared to tumour-free rats.
The data show for the first time a clear relationship between blood lipids and the presence or absence of
large bowel cancer.
The incidence and mortality rates for large bowel cancer are
the second highest of all malignant disease in Western
society (American Cancer Society, 1978). Although the
cause(s) of colon cancer is unknown, epidemiological studies
have implicated dietary fats in the pathogenesis of this
disease (Wynder, 1975; Doll, 1978; Wynder & Reddy, 1983).
More specifically, cholesterol in the diet has been shown to
be co-carcinogenic in animals (Cruse et al., 1978,1982) and
there is indirect evidence for a similar role in man (Cruse et
al., 1979; Broitman, 1981).
Populations at high risk for colorectal cancer (CRC) are
similarly at high risk of coronary heart disease (CHD) (Hill,
1975; Wynder & Shigematsu, 1967) and a common factor for
both diseases is the high fat intake of the 'at risk' population
(Hill, 1975). The familiar direct relationship between serum
cholesterol levels and CHD probably reflects a causal role
between hypercholesterolaemia and atherosclerosis (Lewis,
1983). Recent evidence also indicates that a direct but
inverse relationship also exists between serum cholesterol
and cancer mortality rate (Feinleib, 1983).
Epidemiological studies have looked at plasma lipids and
risk of cancer mortality but no conclusive result has
appeared. A review by McMichael et al. (1984) showed that
in 12 of 20 follow-up studies an inverse association was
observed between blood cholesterol and overall cancer risk.
Two recent reports by Mannes et al. (1986) and Tornberg et
al. (1986) both showed a small positive association between
serum cholesterol and risk of CRC. Saier et al. (1979) have
investigated the ratio of free:esterified cholesterol and have
suggested that changes in this ratio provides a new
discriminant for the presence of malignant disease.
This present study was therefore designed to serially
investigate serum lipid changes in an animal model of colon
cancer at different stages of disease. Particular attention was
paid to the levels of total and free cholesterol and the
tumour stage present.
Materials and methods
Eighty weanling outbred female Wistar rats (Tuck & Sons,
Battlesbridge, Essex) weighing 50-80g were weaned on to a
standard pellet laboratory diet (MRC Formula 41B, Dixon
& Sons, Ware, Herts.) and water, both ad libitum. They
remained on this diet for the duration of the experiment.
The animals were given a regimen of 1,2-dimethyl-
hydrazine dihydrochloride (Aldrich Chemical Co.,
Gillingham, Dorset) known to produce colon cancer. The
carcinogen was prepared according to the method of Filipe
(1975). Each rat received 5 weekly s.c. injections of DMH
(40mgkg-1 body wt) in the left flank. The rats were housed
in temperature controlled quarters in subgroups of five in
suspended cages with open mesh, wire floors designed to
prevent coprophagia thereby avoiding the confounding
effects of the ingestion of faecal mutagens and co-
carcinogens. The animals were weighed weekly and inspected
for signs of illness.
Ten weeks after the first DMH injection and at 5 weekly
intervals thereafter until the 40th week, random groups of
ten rats were anaesthetised, killed by exsanguination and
autopsied. Blood was collected into plain glass tubes, spun at
3000rpm and the serum separated and stored at -20°C for
later assay. The tissues were fixed in 10% formaldehyde and
all macroscopically abnormal colonic tissue was sampled,
processed and embedded in paraffin wax. Sections (5 pm)
were stained routinely with haematoxylin and eosin. Colonic
tumours were histologically classified according to the
method of Cruse et al. (1985) by an independent pathologist.
The serum samples were enzymatically assayed for total
and free cholesterol (Stahler et al., 1977), phospholipids
(Takayama et al., 1977) and triglycerides (Wahlefeld, 1974)
and an aliqutot saved for liver function tests using the SMAC
II automatic analyser. Of the 80 rats induced, 70 were
included in the study while the remaining ten were excluded
when 7 died spontaneously and 3 were killed for humane
reasons. Ten further normal rats were also sacrificed and
served as controls for the liver function tests to assess for the
possible hepatotoxic effects of the carcinogen.
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Table I Sequential changes in mean (±s.e.m.) measured blood parameters with experimental colonic neoplasia
Colonic tumoursper group
Cholesterol mg100ml-1 Serum Serum Alkaline Alanine
phospholipids triglycerides phosphatase transaminase % Total Median
Week Total Free % Free mg 100ml-1 mg 100ml- IU1I 1 IUl-1 Incidence Number (Range)
10 95.0 32.0 33.9 187.1 73.6 123.1 60.7 10 1 0 (0-1)
+5.5 +1.7 +1.3 +6.3 +9.3 +12.4 +3.3
15 119.2 26.9 23.3a 219.0 79.4 101.8 66.9 50 9 1 (0-3)
+12.6 +2.8 +2.4 +12.3 +6.0 +6.3 +12.8
20 114.7 27.0 24.2a 214.2 89.0 119.1 45.9b 90 47 2 (0-18)
+9.3 +2.1 +1.9 +17.9 +16.3 +14.6 +4.9
25 106.0 49Oa 465a 103.9a 82.1 120.3 87.9 100 44 4 (1-11)
+4.2 +2.6 +2.2 +11.8 +12.5 +13.6 +14.9
30 99.7 SO.la 50.7a 112.1a 97.1 98.2 89.0 100 51 4 (1-13)
+6.4 +2.9 +1.8 +10.8 +11.2 +10.2 +11.9
35 125.1 61.4a 49.la 129.3a 117.9 93.8 83.0 90 60 7 (0-13)
+4.0 +2.4 + 1.0 +5.0 +24.7 +12.3 +12.9
40 105.8 52.9a 50.2a 169.4 126.5b 105.6 75.2 100 110 11 (2-20)
+6.3 +3.0 +1.2 +8.5 +17.6 +18.3 +15.2
ap<0.001; bp<0.025 compared to week 10.
The nature of this animal model and the fact that the rats
used were outbred means that at any one time of sacrifice
there was a mixed spectrum of disease present in the group
of rats killed. Consequently, the study was analysed in two
ways. Firstly, the results were examined sequentially over the
40 weeks irrespective of colonic pathology. Secondly, the
results were examined according to tumour pathology and
the animals were allocated into groups that were tumour-free
(n= 16) and those with tumours (n = 54), regardless of the
time at which they were killed. The group with tumours was
further subdivided according to the histological classification
of the tumours into those with adenomas alone (n=8) and
those with carcinomas (n =46). The results were then
statistically analysed by Student t-test for unpaired data.
Results
The sequential results for the serum lipids, liver function
tests and colonic neoplasms are detailed in Table I. There
were no notable changes in total serum cholesterol, alkaline
phosphatase or alanine transaminase despite the increasing
age and tumour burden of the animals over the 40 weeks of
this study. Serum free cholesterol increased significantly from
week 25 onwards (P<0.001) whilst the % free cholesterol
fell at weeks 15 and 20 (P<0.001) then increased from week
25 until the end of the study (P<0.001). The phospholipids
showed a decrease from week 25 onwards (P<0.001) whilst
triglycerides showed an upward trend with time over the
whole study.
The results for the serum lipids with respect to the tumour
pathology, irrespective of time, are shown in Figures 1, 2, 3
and 4. Total serum cholesterol levels did not differ between
any of the 4 groups (Figure 1). In contrast (Figure 2), the
tumour-bearing group had both significantly increased free
(P<0.01) and % free cholesterol (P<0.001) levels compared
to the tumour-free group. The serum phospholipids (Figure
3) showed a similar pattern of changes but in the opposite
direction, with tumour-bearing animals having decreased
phospholipid levels compared to the tumour-free group
(P<0.001). The carcinoma-bearing group was similarly
different to the adenoma alone group (Figure 2), showing
increased free (P<0.01) and % free cholesterol (P<0.001).
The carcinoma-bearing rats also had significantly increased
free (P<0.005) and % free cholesterol (P<0.001) compared
to the tumour-free group. Serum phospholipids were
decreased in carcinoma-bearing rats compared to both the
adenoma alone (P<0.02) and tumour-free groups
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Figure 1 Mean (±s.e.m) serum total cholesterol in the four
experimental groups; 11 all tumour bearing; El tumour free; El
adenomas alone; El carcinomas.
(P<0.001). Serum triglycerides, (Figure 4), were unaltered
by the presence of tumours, no differences being found
between any of the groups.
Impairment of liver function was assessed by changes in
serum alkaline phosphatase, used as a measure of hepatic
duct damage and alanine transaminase which assesses
hepatocellular function. Results showed that neither alkaline
phosphatase nor alanine transaminase differed when
considered sequentially (Table I) or with respect to tumour
status (Table II).
Discussion
This experiment has shown changes in serum lipids in the
presence of DMH-induced colon cancer in rats. It has
demonstrated increased serum free and % free cholesterol
and decreased phospholipid levels in animals when
considered sequentially when the tumour burden was
increasing and when considered according to tumour histo-
pathology, irrespective of time. The latter probably better
reflects the situation that is encountered in man, with
patients presenting at various ages and stages of the disease.SERUM LIPIDS AND EXPERIMENTAL COLON CANCER 453
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Figure 2 Mean (+ s.e.m) serum free and % free cholesterol in the four experimental groups with a statistical comparison; all
tumour bearing; Cl tumour free; El adenomas alone; El carcinomas.
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Figure 3 Mean (±s.e.m) serum phospholipids in the four
experimentsl groups with a statistical comparison; IIII all tumour
bearing; tumour free; E] adenomas alone; EJ carcinomas.
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Figure 4 Mean (±s.e.m) serum
experimental groups; HOl all tumour
adenomas alone; E: carcinomas.
triglycerides in the four
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Table II Mean (±s.e.m.) alkaline phosphatase and alanine
transaminase in controls and in the four experimental groups
Alkaline Alanine
phosphatase transaminase
Groupsa n IUl-1 I1- I
Controls 10 113.8+17.1 78.2+7.5
Tumour free 16 122.6+ 9.3 73.4+9.8
Tumour bearing 54 104.8+ 5.6 72.4+5.2
Adenoma alone 8 93.6+ 11.3 58.8+9.2
Carcinomas 46 105.0+ 6.2 75.0+5.9
aThere were no differences between any of the groups with respect
to alkaline phosphatase or alanine transaminase.
An inverse relationship between serum cholesterol
concentration and cancer mortality has been reported in
population studies, but despite this frequent observation the
evidence relating hypocholesterolaemia and cancer risk
remains controversial (Feinleib, 1983). This may at first seem
at odds with the evidence that high cholesterol intake
increases the risk of colon cancer. One possible explanation
is that individuals on high cholesterol or fat diets either
divert the cholesterol into the vascular compartment and
predispose to hypercholesterolaemia and CHD, or excrete
the excess cholesterol through the intestine and predispose to
colorectal cancer and possible resulting in a below average
blood cholesterol. Associated hypocholesterolaemia was not
found in this study as the total cholesterol levels were
unaffected by the presence of cancer. This may be due to
species differences where rats, unlike man, are resistant to
hypercholesterolaemia and atherosclerosis (Lacko et al.,
1974).
The increase in serum free and % free cholesterol shows a
definite change related to the presence of experimental
tumours and more specifically carcinomas. This supports the
work of Saier et al. (1979) who found in man that the
free:esterified cholesterol ratios were above their normal
range in a whole host of different malignant conditions
including cancer of the large bowel.
The esterification of free cholesterol in the blood is
catalysed by the plasma lecithin:cholesterol acyltransferase
(LCAT) enzyme (Glomset, 1968). This enzyme is produced
in the liver and it has been reported that in liver disease,
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levels of plasma LCAT are reduced resulting in increased
free cholesterol levels (Calandra et al., 1971). The lack of
alteration in liver enzymes in this study implied that the
function of the liver was unimpaired. Development of
cancer, especially in the case of hepatomas, has been noted
to disturb the control of cholesterol metabolism (Siperstein,
1970). It is therefore possible that the cancer itself is
affecting the metabolism of cholesterol by the liver and this
presents as increased levels of circulating free cholesterol.
The observed decrease in serum phospholipids is
supported by two other reports in patients with certain types
of malignant tumours (Nydegger & Butler, 1972) and those
with advanced liver disease and malignancy (Calandra et al.,
1971). Again this observation supports the theory that the
presence of cancer affects the metabolic controls within the
liver. Glomset (1968) reported that exogenous phospholipids
added to serum stimulated cholesterol esterification in vitro.
This introduces the possibility that the increase in free
cholesterol is due to a lack of substrate (phospholipid) for
esterification.
However, it remains controversial whether these changes
are the result of the presence of cancer or whether they are
in some way involved in the aetiology of the disease.
Whatever the mechanism, these parameters do show
consistent changes in the presence of DMH-induced colon
cancer in rats and may prove useful as a serum marker of
malignancy. Serum parameters are easy to measure in man
and assessment of % free cholesterol and phospholipids may
provide a useful aid in the clinical evaluation of cancer
patients.
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